Filters
Documents
Showing 25 of 905 items meeting your criteria.
| Type | Category | Supplier | ||
|---|---|---|---|---|
 | iXCells Products and services designed to empower researchers with innovative solutions that accelerate drug discovery workflows with a focus on disease relevant cellular models: Induced Pluripotent Stem (iPS) Cells, Genome Editing, Targeted Differentiation, Primary Cell Isolation, Integration Free Reprogramming. | |||
Documents | iPSC | iXCells Biotechnologies | ||
 | Lifeline’s Normal Human Skin Cell Systems and optimized Media provide ideal culture models for your critical research of wound healing, skin cancer, burn therapy, dermatological disorders, toxicology, and the screening of cosmetics and skin care products. Additionally, our Xeno-Free Fibroblast cells can be used to establish Xeno-Free human feeder layers for stem cells. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline’s Male Reproductive Cells, when grown in Lifeline brand culture media, provide excellent in vitro models for the study of male reproductive biology. Lifeline’s Male Reproductive Cell Systems can be used as normal controls for cancer cell studies. These products are also ideal for the study of androgen receptors and prostate cellular proliferation; the study of reproductive cell morphogenesis; and for cytotoxicity and drug discovery studies. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline’s Human Lung Cells, when grown in Lifeline brand culture medium, provide ideal culture models for the study of pulmonary diseases such as Asthma, COPD, Cystic Fibrosis, Lung Cancer, as well as the effects of smoking on respiratory health. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline’s Normal Human Dermal Fibroblasts have been validated for their ability to become Induced Pluripotent Stem Cells (iPS). Neonatal Fibroblast Cells, LOT # 00866, can be transduced with lentiviral vectors with very high efficiencies. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline provides Mesenchymal Stem Cells from different anatomical sites. HMSC-Ad are isolated from adipose tissue. HMSC-BM are isolated from bone marrow tissue. HMSC-WJ are isolated from Wharton’s Jelly of the umbilical cord. HMSC-Pre-Adipocyte are isolated from mature adipocytes. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline’s Normal Human Fibroblast Cells, when grown in Lifeline brand culture medium, provide ideal cell system to study wound healing, toxicology, cancer, or basic cell biology in various organs including skin, lung, bladder, and the reproductive systems. Our normal Human Fibroblasts can also be used for drug screening, drug development, and genome editing applications. Additionally, our fibroblasts are ideal for establishing serum free human feeder layers for human embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and other cell culture applications requiring feeder layers. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline’s Normal Human Female Reproductive Cells, when grown in Lifeline brand culture medium, provide ideal in vitro models for uterine contraction and relaxation studies; uterine, cervical, Fallopian tube, and vaginal cancer studies; general reproductive biology studies; and specific responses to oestrogen and other female reproductive hormones. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline’s Normal Human Endothelial Cells provide an ideal cell system to study angiogenesis, cancer, wound healing, atherosclerosis, inflammation, or vascular biology. Additionally, these cells can also be used for drug development or screening. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Lifeline’s Bladder Cells are cryopreserved at the end of secondary culture to ensure the highest viability and plating efficiency. Our Bladder Apex Epithelial Cells and Bladder Dome Epithelial Cells are cultured in UroLife™ Medium. | |||
Documents | Primary Cells | Lifeline Cell Technology | ||
 | Their unique characteristics give them the capability to bind to multiple epitopes of a single antigen. This makes polyclonal antibodies a flexible and reliable tool for researchers and developers of diagnostic assays. ProScis Custom Antibody Services Team has over 24 years experience in designing, developing, and purifying polyclonal, monoclonal, and recombinant antibodies. | |||
Documents | Antibodies | ProSci | ||
 | Poxviruses are viruses from the Poxviridae family. This family of viruses includes several types of infectious viruses that affect both humans and animals. One of the most recognized viruses in Poxviridae is smallpox which has been mostly eradicated with the use of vaccines, while other strains such as the monkeypox virus have been spreading in countries around the world. Many viruses in the Poxviridae family have genetic similarities which allows many of the same research tools to be used on multiple viral species. | |||
Documents | Virology | ProSci | ||
 | ProSci is the leading supplier in antibodies and proteins for cytokine research. Our list includes interferons (IF), interleukins (ILs), tumor necrosis factor (TNF), chemokines, colony stimulating factors (CSFs), and growth factors. | |||
Documents | Cytokines | ProSci | ||
 | ProSci Inc. has developed several new classes of reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, and its ligands PD-L1 and PD-L2. These classes of products included highly validated Risk Free™ mouse monoclonal antibodies (mAbs), llama single domain antibodies, rabbit polyclonal antibodies, as well as recombinant proteins, tissue and cell slides and lysates. These products should prove useful in basic research, diagnostics, and drug development in the field of cancer immunotherapy. | |||
Documents | Immunology | ProSci | ||
 | Vitro Biopharma specialises in cancer-associated fibroblasts, mesenchymal stem cells, normal fibroblasts, and cell culture media designed to meet the diverse needs of researchers. They pride themselves on delivering innovative solutions that enhance efficiency, productivity, and overall success. | |||
Documents | Primary Cells | Vitro Biopharma | ||
 | Demand for antibodies against dsRNA continues to grow with the success of mRNA vaccines in the fight against COVID-19. Current mRNA technology, where mRNA is transcribed from cloned DNA by the T7 RNA polymerase, results in the creation of dsRNA impurities. To monitor the removal of this unwanted dsRNA by-product before use, Scicons antibodies are the gold standard. | |||
Documents | Antibodies | Nordic MUbio | ||
 | Nordic-MUbio is dedicated to helping veterinary scientists advance their understanding of animal immunology, helping to safeguard everything from domestic pets to livestock in health and disease. | |||
Documents | Antibodies | Nordic MUbio | ||
 | Antibodies and Reagents that Answer Real Needs. FIX&PERM, BrdU, SPARC, Chicken IgY, Custom Chicken IgY Services. | |||
Documents | Antibodies | Nordic MUbio | ||
 | OmicsLinkTM shRNA clone collections consist of lentiviral and other mammalian expression vector-based small hairpin RNA (shRNA) clones against genome-wide target genes from human, mouse and rat. A set of four expression constructs for every target gene ensures high knockdown efficiency with minimal off-target effects. | |||
Documents | Clones | GeneCopoeia | ||
 | Luciferase + GFP Dual Labeled Cancer Cell Lines
GeneCopoeia offers premade stable cancer cell lines with dual labels (luciferase + GFP). They are ready to use and express high levels of luciferase and GFP. | |||
Documents | Cell lines | GeneCopoeia | ||
 | GeneCopoeia offers genome-edited cell lines that carry diverse hotspot mutations commonly seen in the cancer signaling pathways including EGFR, KRAS and BRAF, in both homozygous and heterozygous genotypes | |||
Documents | Cell lines | GeneCopoeia | ||
 | Designed for microRNA (miRNA) target identification and functional validation of predicted targets, or to study the regulatory effect of miRNA on target genes. | |||
Documents | miRNA | GeneCopoeia | ||
 | For in vitro and in vivo applications | |||
Documents | Lentiviral particles | GeneCopoeia | ||
 | GeneCopoeia, Inc. a U.S.-based functional genomics company founded in 1999, develops cutting-edge products and services for genomics, proteomics, and molecular and cellular biology. With emphasis on innovative R&D and superior product quality, GeneCopoeia serves the needs of biomedical scientists in academic research, and R&D of pharmaceutical and diagnostic products in their pursuit of discoveries and innovations. | |||
Documents | Molecular Biology | GeneCopoeia | ||
 | GeneHero™ Cas9 Stable Cell Lines
Reporter-Gene Labeled Cancer Cell Lines
OncoSpot™ Cancer Biomarker Mutant Cell Lines | |||
Documents | Cell lines | GeneCopoeia | ||